NTRK1 and cancer: The ERBB signaling pathway (Figure 5c), mediated by ERBB receptor tyrosine kinases (ERBB-1/EGFR, ERBB-2/HER2, ERBB-3, and ERBB-4), is crucial for cellular proliferation, survival, migration, and angiogenesis, which leads to cancer progression.